These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27228041)

  • 1. What is the role of concentrated insulin in diabetes management?
    Mospan CM
    JAAPA; 2016 Jun; 29(6):16-8. PubMed ID: 27228041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrated insulins in current clinical practice.
    Schloot NC; Hood RC; Corrigan SM; Panek RL; Heise T
    Diabetes Res Clin Pract; 2019 Feb; 148():93-101. PubMed ID: 30583034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding concentrated insulins: a systematic review of randomized controlled trials.
    Ovalle F; Segal AR; Anderson JE; Cohen MR; Morwick TM; Jackson JA
    Curr Med Res Opin; 2018 Jun; 34(6):1029-1043. PubMed ID: 29166786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The short-acting insulin analog Lispro (Humalog) in the treatment of diabetes--comparison of preprandial and postprandial administration and comparison with treatment using Humulin R].
    Perusicová J; Svehelka JM
    Vnitr Lek; 1998 Jul; 44(7):409-14. PubMed ID: 9748877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating advances in insulin into clinical practice: Advances In insulin formulations.
    King A
    J Fam Pract; 2013 Sep; 62(9 Suppl Insulin):S9-17. PubMed ID: 24080573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why Do Some Concentrated Insulins Maintain Their Pharmacokinetics/Pharmacodynamics Profile?
    Hood RC
    Diabetes Technol Ther; 2017 Apr; 19(4):203-205. PubMed ID: 28418731
    [No Abstract]   [Full Text] [Related]  

  • 7. Eli Lilly and Company Insulins - A Century of Innovation.
    Malone JK; Anderson JHJ; Wolpert HA; Ilag LL; Frank BH; De Felippis MR; Paavola CD; Orr AL; Beals JM
    Pediatr Endocrinol Rev; 2020 Mar; 17(Suppl 1):138-160. PubMed ID: 32208559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher concentration insulins: an overview of clinical considerations.
    Reid TS; Schafer F; Brusko C
    Postgrad Med; 2017 Jun; 129(5):554-562. PubMed ID: 28475455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin confusion: an observation.
    Phillips W; Lando H
    Diabetes Care; 2002 Jun; 25(6):1103-4. PubMed ID: 12032129
    [No Abstract]   [Full Text] [Related]  

  • 10. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
    Peterson GE
    Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus.
    Dunn CJ; Plosker GL
    Pharmacoeconomics; 2002; 20(14):989-1025. PubMed ID: 12403639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insulins and New Aspects in Insulin Delivery.
    Woo VC
    Can J Diabetes; 2015 Aug; 39(4):335-43. PubMed ID: 26233724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulins for type 2 diabetes.
    Med Lett Drugs Ther; 2019 May; 61(1571):65-68. PubMed ID: 31169803
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of fixed-mixture insulins in clinical practice.
    Turner HE; Matthews DR
    Eur J Clin Pharmacol; 2000 Apr; 56(1):19-25. PubMed ID: 10853873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel insulins and strict glycemic control. Analogues approximate normal insulin secretory response.
    White JR; Campbell RK; Hirsch IB
    Postgrad Med; 2003 Jun; 113(6):30-6. PubMed ID: 12838802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin: Making Sense of Current Options.
    Segal AR; Vootla T; Beaser RS
    Endocrinol Metab Clin North Am; 2016 Dec; 45(4):845-874. PubMed ID: 27823608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin lispro, a new insulin analog.
    Kucera ML; Graham JP
    Pharmacotherapy; 1998; 18(3):526-38. PubMed ID: 9620104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin lispro: a fast-acting insulin analog.
    Noble SL; Johnston E; Walton B
    Am Fam Physician; 1998 Jan; 57(2):279-86, 289-92. PubMed ID: 9456992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Concentrated Insulin Delivery Devices: Developments for Safe and Simple Dose Conversions.
    Johnson JL; Downes JM; Obi CK; Asante NB
    J Diabetes Sci Technol; 2017 May; 11(3):618-622. PubMed ID: 27898390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes?
    Maiorino MI; Petrizzo M; Capuano A; Giugliano D; Esposito K
    Expert Opin Biol Ther; 2014 Jun; 14(6):799-808. PubMed ID: 24673155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.